Ftse Mib
35.921,63
0,19%
DAX
21.290,52
0,15%
S&P 500
6.086,37
0,61%
NASDAQ
20.009,34
1,28%
Bitcoin
101.548,80
-2,02%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Selecta Biosciences Inc (SELB) Selecta Biosciences Inc (SELB) Notizie

Selecta Biosciences Inc

SELB
0,8812
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/9/202413:03EDGAR2Form 8-K - Current report
20/9/202422:17EDGAR2Form S-1/A - General form for registration of securities..
09/9/202422:11EDGAR2Form S-1/A - General form for registration of securities..
16/8/202422:02EDGAR2Form DEF 14A - Other definitive proxy statements
08/8/202413:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:04EDGAR2Form 8-K - Current report
02/8/202413:45EDGAR2Form PRE 14A - Other preliminary proxy statements
02/8/202413:34EDGAR2Form S-1 - General form for registration of securities under..
17/7/202417:45EDGAR2Form D - Notice of Exempt Offering of Securities
03/7/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202422:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/7/202412:30EDGAR2Form 8-K - Current report
17/6/202413:54EDGAR2Form 8-K - Current report
22/5/202413:08EDGAR2Form 8-K - Current report
08/5/202413:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:03EDGAR2Form 8-K - Current report
26/4/202415:09EDGAR2Form DEF 14A - Other definitive proxy statements
26/4/202413:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/4/202412:25EDGAR2Form 8-K - Current report
19/4/202422:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/4/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/4/202422:29EDGAR2Form SC 13D/A - General statement of acquisition of..
10/4/202422:25EDGAR2Form SC 13D/A - General statement of acquisition of..
10/4/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/4/202413:00EDGAR2Form 8-K - Current report
01/4/202422:32EDGAR2Form 8-K - Current report
28/3/202422:00EDGAR2Form 8-K - Current report
14/3/202412:55EDGAR2Form 8-K - Current report
07/3/202413:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:06EDGAR2Form 8-K - Current report
05/3/202413:05EDGAR2Form 8-K - Current report
14/2/202423:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/2/202422:42EDGAR2Form DEF 14A - Other definitive proxy statements
14/2/202418:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:30EDGAR2Form PRE 14A - Other preliminary proxy statements
Apertura: Min: Max:
Chiusura: 0,8812

La tua Cronologia

NASDAQ
SELB
Selecta Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network